MXPA04009582A - Combinaciones de epinastina, belladona y pseudoefedrina como nuevas formulaciones farmaceuticas. - Google Patents

Combinaciones de epinastina, belladona y pseudoefedrina como nuevas formulaciones farmaceuticas.

Info

Publication number
MXPA04009582A
MXPA04009582A MXPA04009582A MXPA04009582A MXPA04009582A MX PA04009582 A MXPA04009582 A MX PA04009582A MX PA04009582 A MXPA04009582 A MX PA04009582A MX PA04009582 A MXPA04009582 A MX PA04009582A MX PA04009582 A MXPA04009582 A MX PA04009582A
Authority
MX
Mexico
Prior art keywords
pharmaceutically acceptable
acceptable salt
pseudoephedrine
sustained release
layer
Prior art date
Application number
MXPA04009582A
Other languages
English (en)
Spanish (es)
Inventor
Seko Noritaka
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of MXPA04009582A publication Critical patent/MXPA04009582A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MXPA04009582A 2002-04-03 2003-03-28 Combinaciones de epinastina, belladona y pseudoefedrina como nuevas formulaciones farmaceuticas. MXPA04009582A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02007568A EP1350512A1 (en) 2002-04-03 2002-04-03 Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations
PCT/EP2003/003263 WO2003082285A1 (en) 2002-04-03 2003-03-28 Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations

Publications (1)

Publication Number Publication Date
MXPA04009582A true MXPA04009582A (es) 2005-01-11

Family

ID=27838061

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04009582A MXPA04009582A (es) 2002-04-03 2003-03-28 Combinaciones de epinastina, belladona y pseudoefedrina como nuevas formulaciones farmaceuticas.

Country Status (12)

Country Link
US (1) US20030228359A1 (cg-RX-API-DMAC7.html)
EP (2) EP1350512A1 (cg-RX-API-DMAC7.html)
JP (1) JP2005522467A (cg-RX-API-DMAC7.html)
AR (1) AR039221A1 (cg-RX-API-DMAC7.html)
AU (1) AU2003221532A1 (cg-RX-API-DMAC7.html)
BR (1) BR0308982A (cg-RX-API-DMAC7.html)
CA (1) CA2477751A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA04009582A (cg-RX-API-DMAC7.html)
PE (1) PE20040080A1 (cg-RX-API-DMAC7.html)
PL (1) PL371382A1 (cg-RX-API-DMAC7.html)
RU (1) RU2004132205A (cg-RX-API-DMAC7.html)
WO (1) WO2003082285A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2366446C1 (ru) * 2008-06-27 2009-09-10 Сергей Анатольевич Небера Гомеопатическое средство для лечения конъюнктивитов

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
US20030104017A1 (en) * 2001-10-26 2003-06-05 Boehringer Ingelheim International Gmbh Epinastine formulation for oral administration
KR20050092429A (ko) * 2003-01-22 2005-09-21 니찌방 가부시기가이샤 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환치료약의 눈의 국소 조직으로의 이행 방법
JP2007517766A (ja) * 2003-09-24 2007-07-05 コンビナトアールエックス インコーポレーティッド 薬物の組み合わせを投与するための治療法
AU2005210086A1 (en) * 2004-02-06 2005-08-18 Meda Pharma Gmbh & Co. Kg Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids
JP4936420B2 (ja) * 2005-08-02 2012-05-23 塩野義製薬株式会社 徐放性顆粒剤
JP5162141B2 (ja) * 2007-02-20 2013-03-13 エスエス製薬株式会社 フィルムコーティング用組成物
WO2010030418A1 (en) * 2008-09-10 2010-03-18 Micro-Dose Life Sciences Llc Anti-fever botanical composition and uses thereof
RU2567032C2 (ru) * 2009-05-01 2015-10-27 Апталис Фарматек, Инк. Перорально распадающиеся таблеточные композиции, содержащие комбинации неопиоидных и опиоидных анальгетиков
JP5852816B2 (ja) * 2010-09-10 2016-02-03 ロート製薬株式会社 液状医薬組成物、及びこれを含有する軟カプセル剤
RU2478377C1 (ru) * 2011-08-08 2013-04-10 Алексей Владимирович Брынцалов Комбинированный препарат орвиум для устранения симптомов простудных заболеваний и гриппа
CN110237079B (zh) * 2019-07-01 2021-05-14 山西大学 一种百部生物碱类似物的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10298107A (ja) * 1997-04-25 1998-11-10 Taisho Pharmaceut Co Ltd 医薬組成物
US6613357B2 (en) * 2000-01-13 2003-09-02 Osmotica Corp. Osmotic device containing pseudoephedrine and an H1 antagonist

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2366446C1 (ru) * 2008-06-27 2009-09-10 Сергей Анатольевич Небера Гомеопатическое средство для лечения конъюнктивитов

Also Published As

Publication number Publication date
AR039221A1 (es) 2005-02-09
EP1350512A1 (en) 2003-10-08
PE20040080A1 (es) 2004-04-22
CA2477751A1 (en) 2003-10-09
PL371382A1 (en) 2005-06-13
AU2003221532A1 (en) 2003-10-13
RU2004132205A (ru) 2005-09-10
US20030228359A1 (en) 2003-12-11
WO2003082285A1 (en) 2003-10-09
BR0308982A (pt) 2005-01-04
JP2005522467A (ja) 2005-07-28
EP1492532A1 (en) 2005-01-05

Similar Documents

Publication Publication Date Title
RU2141822C1 (ru) Новые гранулы для регулируемого высвобождения и фармацевтические препараты, содержащие такие гранулы
KR101234940B1 (ko) 안정한 서방출형의 경구 투여용 조성물
US5807579A (en) Pseudoephedrine combination pharmaceutical compositions
US20120100221A1 (en) Pharmaceutical compositions containing a combination of an antihistamine and a decongestant
US20020031550A1 (en) Controlled release dosage form of [R-(Z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2.2]oct-3yl) acetonitrile monohydrochloride
AU724086B2 (en) Controlled release dosage form of (R-(Z))-alpha- (methoxyimino)-alpha-(1-azabicyclo(2.2.2)oct-3-yl) acetonitrile monohydrochloride
US20030228359A1 (en) Pharmaceutical formulations containing epinastine, belladonna, and pseudoephedrine
JP2005522467A5 (cg-RX-API-DMAC7.html)
US20050084527A1 (en) Pharmaceutical formulations containing combinations of epinastine, pseudoephedrine, and methylephedrine
MX2008016565A (es) Composiciones farmaceuticas que comprenden una combinacion de piperidinoalcanol y descongestivo.
US20020094345A1 (en) Pharmaceutical compositions containing epinastine and pseudoephedrine
WO2011027322A1 (en) Extended release dosage form containing olopatadine for oral administration
CN101756981A (zh) 一种布洛氯雷伪麻缓释制剂及其制备方法
JP2005519053A (ja) 放出が改良された薬剤
CZ2003945A3 (cs) Farmaceutický prostředek
AU2002212290A1 (en) New pharmaceutical compositions containing epinastine and pseudoephedrine
JP2006510639A (ja) エフレチリジン及びプソイドエフェドリンを含む錠剤
EP3474825B1 (en) Sustained release formulation comprising tizanidine
KR101199654B1 (ko) 안정한 서방출형의 경구 투여용 조성물
EP1809255A1 (en) High-dosage extended-release formulation of gepirone
JP2006509789A (ja) 不安症治療法及び治療薬
KR20060021671A (ko) 벤라팍신 하이드로클로라이드 함유 서방성 제제
HK1034453B (en) Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
NZ554916A (en) High-dosage extended-release formulation of gepirone
HK1141720A (en) Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine